Author:
Hegedüs Zsófia,Wéber Edit,Végh Lea,Váczi Balázs,Tubak Vilmos,Kriston-Pál Éva,Kele Zoltán,Monostori Éva,Martinek Tamás A.
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Griffioen AW, Barendsz-Janson AF, Mayo KH, Hillen HF. Angiogenesis, a target for tumor therapy. J Lab Clin Med. 1998;132:363–8.
2. Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev. 2000;52:237–68.
3. Ruegg C, Hasmim M, Lejeune FJ, Alghisi GC. Antiangiogenic peptides and proteins: from experimental tools to clinical drugs. Biochim Biophys Acta. 2006;1765:155–77. doi: 10.1016/j.bbcan.2005.09.003 .
4. Griffioen AW. Therapeutic approaches of angiogenesis inhibition: are we tackling the problem at the right level? Trends Cardiovasc Med. 2007;17:171–6. doi: 10.1016/j.tcm.2007.03.007 .
5. Griffioen AW, van der Schaft DW, Barendsz-Janson AF, Cox A, Struijker Boudier HA, Hillen HF, et al. Anginex, a designed peptide that inhibits angiogenesis. Biochem J. 2001;354:233–42.